{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:09:34Z","timestamp":1792822174770,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,2,17]],"date-time":"2014-02-17T00:00:00Z","timestamp":1392595200000},"content-version":"vor","delay-in-days":3609,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.joca.2003.11.008","type":"journal-article","created":{"date-parts":[[2004,1,12]],"date-time":"2004-01-12T08:55:03Z","timestamp":1073897703000},"page":"284-295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Site specific changes in gene expression and cartilage metabolism during early experimental osteoarthritis"],"prefix":"10.1016","volume":"12","author":[{"given":"H.","family":"Dumond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Presle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Pottie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pacquelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Terlain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Netter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gepstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Livne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-Y.","family":"Jouzeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joca.2003.11.008_BIB1","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1056\/NEJM198905183202006","article-title":"The biology of osteoarthritis","volume":"320","author":"Hamerman","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joca.2003.11.008_BIB2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1297-319X(00)00214-1","article-title":"Interest of animal models in the preclinical screening of anti-osteoarthritic drugs","volume":"67","author":"Jouzeau","year":"2000","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.joca.2003.11.008_BIB3","first-page":"335","article-title":"Proteoglycan synthesis and osteophyte formation in \u2018metabolically\u2019 and \u2018mechanically\u2019 induced murine degenerative joint disease: an in-vivo autoradiographic study","volume":"73","author":"van der Kraan","year":"1992","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.joca.2003.11.008_BIB4","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/jor.1100120204","article-title":"Site-specific cartilage changes in murine degenerative knee joint disease induced by iodoacetate and collagenase","volume":"12","author":"van Osch","year":"1994","journal-title":"J Orthop Res"},{"key":"10.1016\/j.joca.2003.11.008_BIB5","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/art.1780400917","article-title":"Mono-iodoacetate-induced experimental osteoarthritis: a dose-response study of loss of mobility, morphology, and biochemistry","volume":"40","author":"Guingamp","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2003.11.008_BIB6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/03008209909005273","article-title":"The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models","volume":"40","author":"Goldring","year":"1999","journal-title":"Connect Tissue Res"},{"key":"10.1016\/j.joca.2003.11.008_BIB7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1042\/bj1840177","article-title":"A cartilage catabolic factor from synovium","volume":"184","author":"Dingle","year":"1979","journal-title":"Biochem J"},{"key":"10.1016\/j.joca.2003.11.008_BIB8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1042\/bj2240461","article-title":"Pig catabolin is a form of interleukin 1. Cartilage and bone resorb, fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein","volume":"224","author":"Saklatvala","year":"1984","journal-title":"Biochem J"},{"key":"10.1016\/j.joca.2003.11.008_BIB9","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/art.1780390914","article-title":"Chondroprotectiveeffect of intra-articular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression","volume":"39","author":"Caron","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2003.11.008_BIB10","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/art.1780400604","article-title":"In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy","volume":"40","author":"Pelletier","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2003.11.008_BIB11","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/1529-0131(199807)41:7<1141::AID-ART2>3.0.CO;2-S","article-title":"The role of nitric oxide in inflammation and immunity","volume":"41","author":"Clancy","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2003.11.008_BIB12","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1053\/joca.1998.0219","article-title":"Human chondrocyte culture models for studying cyclooxygenase expression and prostaglandin regulation of collagen gene expression","volume":"7","author":"Goldring","year":"1999","journal-title":"Osteoarthritis Cart"},{"key":"10.1016\/j.joca.2003.11.008_BIB13","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1172\/JCI119280","article-title":"Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide","volume":"99","author":"Amin","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.joca.2003.11.008_BIB14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/joca.1998.0216","article-title":"Nitric oxide in osteoarthritis","volume":"7","author":"Studer","year":"1999","journal-title":"Osteoarthritis Cart"},{"key":"10.1016\/j.joca.2003.11.008_BIB15","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/1529-0131(199807)41:7<1266::AID-ART18>3.0.CO;2-Y","article-title":"Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis","volume":"41","author":"Hashimoto","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2003.11.008_BIB16","first-page":"75","article-title":"Chondrocyte apoptosis induced by nitric oxide","volume":"146","author":"Blanco","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1016\/j.joca.2003.11.008_BIB17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1042\/bj3240305","article-title":"Nitric oxide inhibits the synthesis of type-II collagen without altering Col2A1 mRNA abundance: prolyl hydroxylase as a possible target","volume":"324","author":"Cao","year":"1997","journal-title":"Biochem J"},{"key":"10.1016\/j.joca.2003.11.008_BIB18","first-page":"237","article-title":"Therole of cytokines in osteoarthritis pathophysiology","volume":"39","author":"Fernandes","year":"2002","journal-title":"Biorheology"},{"key":"10.1016\/j.joca.2003.11.008_BIB19","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/(SICI)1097-4644(19970601)65:3<408::AID-JCB10>3.0.CO;2-B","article-title":"Prostaglandin E2 stimulates insulin-like growth factor binding protein-4 expression and synthesis in cultured human articular chondrocytes: possible mediation by Ca(++)-calmodulin regulated processes","volume":"65","author":"Di Battista","year":"1997","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.joca.2003.11.008_BIB20","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/art.10356","article-title":"Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants","volume":"46","author":"Hardy","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2003.11.008_BIB21","doi-asserted-by":"crossref","first-page":"12243","DOI":"10.1074\/jbc.275.16.12243","article-title":"Evidence for the presence of peroxisome proliferator-activated receptor (PPAR) alpha and gamma and retinoid Z receptor in cartilage. PPARgamma activation modulates the effects of interleukin-1beta on rat chondrocytes","volume":"275","author":"Bordji","year":"2000","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.joca.2003.11.008_BIB22","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/1529-0131(200103)44:3<595::AID-ANR108>3.0.CO;2-8","article-title":"Peroxisome proliferator\u2013activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes","volume":"44","author":"Fahmi","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2003.11.008_BIB23","first-page":"3","article-title":"PPARgamma ligands as modulators of inflammatory and catabolic responses in arthritis. An overview","volume":"29","author":"Fahmi","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.joca.2003.11.008_BIB24","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/joca.2001.0472","article-title":"Moderation of iodoacetate-induced experimental osteoarthritis in rats by matrix metalloproteinase inhibitors","volume":"9","author":"Janusz","year":"2001","journal-title":"Osteoarthritis Cart"},{"issue":"3","key":"10.1016\/j.joca.2003.11.008_BIB25","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/art.1780390316","article-title":"The superficial layer of human articular cartilage is more susceptible to interleukin-1-induced damage than the deeper layers","volume":"39","author":"Hauselmann","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2003.11.008_BIB26","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0898-6568(01)00281-9","article-title":"Natural ligands of PPARgamma: are prostaglandin J(2) derivatives really playing the part?","volume":"14","author":"Nosjean","year":"2002","journal-title":"Cell Signal"},{"key":"10.1016\/j.joca.2003.11.008_BIB27","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/art.10052","article-title":"Peroxisome proliferator-activated receptor gamma agonists: potential use for treating chronic inflammatory diseases","volume":"46","author":"Oates","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2003.11.008_BIB28","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1053\/joca.2002.0832","article-title":"Induction of cyclooxygenase-2 by mechanical stress through a nitric oxide-regulated pathway","volume":"10","author":"Fermor","year":"2002","journal-title":"Osteoarthritis Cart"},{"key":"10.1016\/j.joca.2003.11.008_BIB29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/joca.1998.0170","article-title":"Altered mechanics of cartilage with osteoarthritis: human osteoarthritis and an experimental model of joint degeneration","volume":"7","author":"Setton","year":"1999","journal-title":"Osteoarthritis Cart"},{"key":"10.1016\/j.joca.2003.11.008_BIB30","first-page":"125","article-title":"The effects of pressure on chondrocyte tumour necrosis factor receptor expression","volume":"39","author":"Westacott","year":"2002","journal-title":"Biorheology"},{"key":"10.1016\/j.joca.2003.11.008_BIB31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/joca.1998.0109","article-title":"Osteoarthritic synovial fluid and synovium supernatants up-regulate tumor necrosis factor receptors on human articular chondrocytes","volume":"6","author":"Webb","year":"1998","journal-title":"Osteoarthritis Cart"},{"key":"10.1016\/j.joca.2003.11.008_BIB32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1053\/joca.1999.0292","article-title":"Tumor necrosis factor alpha can contribute to focal loss of cartilage in osteoarthritis","volume":"8","author":"Westacott","year":"2000","journal-title":"Osteoarthritis Cart"},{"key":"10.1016\/j.joca.2003.11.008_BIB33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/1529-0131(200001)43:1<195::AID-ANR24>3.0.CO;2-G","article-title":"Autocrine regulation of collagenase 3 (matrix metalloproteinase 13) during osteoarthritis","volume":"43","author":"Shlopov","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2003.11.008_BIB34","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1053\/joca.2002.0515","article-title":"Susceptibility to physiological concentrations of IL-1beta varies in cartilage at different anatomical locations on human osteoarthritic knee joints","volume":"10","author":"Barakat","year":"2002","journal-title":"Osteoarthritis Cart"}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458403003078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458403003078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:03:41Z","timestamp":1761015821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458403003078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S1063458403003078"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2003.11.008","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Site specific changes in gene expression and cartilage metabolism during early experimental osteoarthritis","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2003.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}